DAK-Gesundheit claim that cost saving measures imposed by the GVK Financial Stabilisation Act are un...
Read moreCMS denies coverage of FDA-approved treatments that target amyloid for Alzheimer's disease unless th...
Read moreNICE conditionally recommends eight digitally enabled therapies to treat depression and anxiety in a...
Read moreFimea program aims to standardise the initiation of assessment which are currently different for out...
Read moreThe Project Orbis initiative is an international partnership between medicines regulators in the UK,...
Read moreCollectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...
Read moreProject to help the EU develop new pricing and payment models to fund high-priced drugs and relieve ...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read more